Skip to Main Content
Skip Nav Destination
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

By transfusing an amount of Glyco-Algin equal to that of blood lost in bleeding, lowered blood pressure is restored to 95% of normal. In addition Glyco-Algin holds the blood pressure at 80% of normal even after a 90 minute lapse.This is due to the mechanism which inhibits the increase of extracellular fluid and greatly increases the plasma volume of circulating blood. In accordance with the above, plasma volume and corpuscle count is restored by the aforesaid transfusion to conditions prior to bleeding. Moreover, when drop infusion is administered to study clinical application, the above characteristics of Glyco-Algin appear more strongly, with 10 drops per kilogram of body weight per minute the lowered blood pressure induced by bleeding begins to ascend from the time of infusion. A well ordered upward curve results. Even in rapid infusion (40 drops per minute) the results are approximately the same.Studies on kidney functions revealed the following. Slow drop intravenous transfusion increases circulating blood volume in kidney and heightens blood velocity in the same and expedites diuretic action. Moreover, Glyco-Algin inhibitsthe transudation from the cardiovascular system to tissues while, on the other hand, it promotes the process of filtration and excretion of glomerulus without reverse influences on the tubular reabsorption.Studies on the correlation of blood sugar increase and operative invasions were conducted to determine influences on the metabolism of carbohydrates. As compared with glucose solution, the rise of blood sugar induced by Glyco-Algin transfusion is a mere 50% of that of the former. When operations are not performed, glycosuria does not appear and the increase of blood sugar is slight.

Send Email

Recipient(s) will receive an email with a link to 'International Society of Blood Transfusion6th Congress in Conjunction with the 9th Annual Meeting of the American Association of Blood Banks, Boston, Mass., September 1956: Proceedings > 287a - 288: Glyco-Algin as a Transfusion Solution' and will not need an account to access the content.

Subject: International Society of Blood Transfusion6th Congress in Conjunction with the 9th Annual Meeting of the American Association of Blood Banks, Boston, Mass., September 1956: Proceedings > 287a - 288: Glyco-Algin as a Transfusion Solution

(Optional message may have a maximum of 1000 characters.)

×

or Create an Account

Close Modal
Close Modal